Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $64.9 million.

  • Sanara MedTech's Total Liabilities rose 3230.09% to $64.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.9 million, marking a year-over-year increase of 3230.09%. This contributed to the annual value of $49.2 million for FY2024, which is 6794.66% up from last year.
  • As of Q3 2025, Sanara MedTech's Total Liabilities stood at $64.9 million, which was up 3230.09% from $63.4 million recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Total Liabilities registered a high of $64.9 million during Q3 2025, and its lowest value of $3.5 million during Q1 2021.
  • Moreover, its 5-year median value for Total Liabilities was $19.3 million (2022), whereas its average is $27.0 million.
  • In the last 5 years, Sanara MedTech's Total Liabilities tumbled by 780.6% in 2021 and then soared by 27353.59% in 2022.
  • Over the past 5 years, Sanara MedTech's Total Liabilities (Quarter) stood at $6.2 million in 2021, then skyrocketed by 209.32% to $19.3 million in 2022, then soared by 51.61% to $29.3 million in 2023, then soared by 67.95% to $49.2 million in 2024, then skyrocketed by 32.06% to $64.9 million in 2025.
  • Its last three reported values are $64.9 million in Q3 2025, $63.4 million for Q2 2025, and $59.7 million during Q1 2025.